Clinical Trial Update: Linezolid to Treat Extensively-Drug Resistant Tuberculosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating linezolid for extensively drug-resistant tuberculosis has completed, with results posted in 2014. The study encompassed pulmonary tub…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensively Drug-resistant Tuberculosis
• Multidrug-resistant Tuberculosis
• Pulmonary Tuberculosis

Drugs mentioned

• ZYVOX (LINEZOLID)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pulmonary Tuberculosis, Multidrug Resistant Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2014-02-24